Prism Medico and Pharmacy Ltd (PRISMMEDI)

Loading page…

Prism Medico and Pharmacy Ltd (PRISMMEDI) · mywealthgrid

About

Prism Medico and Pharmacy Ltd operates in Non Banking Financial Company (NBFC) within the Financials sector.

Face value: ₹10

Market cap

₹39 Cr

P/E

—

P/B

2.6×

Dividend yield

ROE

2.1%

ROCE

2.8%

Debt / equity

OPM

16.4%

EPS (TTM)

₹-0.2

Book value

₹11.3

52-week high

—

52-week low

—

2,187 historical price candles were omitted because the exchange source has not been verified.

₹29.0+0%1Y

Quick read

rule-based

Pros

+Almost debt-free (debt/equity 0)

Cons

−Low return on equity of 0.5% (3-yr avg)
−Revenue shrank over the last 5 years (-32% a year)

Research score

Structured signal from quality, growth, valuation and momentum.

59/100

Business quality: 34
Growth: 49
Valuation: 93

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	—	—	21	36	27	17	8	1	3	1	2
Interest	—	—	—	—	—	0	0	0	0	0	0
Expenses	0	0	21	36	27	17	9	1	3	1	2
Financing profit	—	—	—	—	—	-0	-0	-0	-0	-0	0
Financing margin %	—	—	—	—	—	-1%	-5.8%	-7.1%	-4.8%	-12.7%	16.4%
Other income	—	—	—	—	—	0	0	0	0	0	0
Depreciation	—	—	—	0	—	0	0	0	0	0	0
Profit before tax	-0	-0	0	0	0	-0	-1	-0	-0	-0	0
Tax	—	—	—	—	—	-0	-0	-0	-0	-0	0
Tax %	—	—	—	—	—	-27.8%	-26%	-30%	-33.3%	-28.6%	25.6%
PAT	-0	-0	-0	0	0	-0	-0	-0	-0	-0	0
EPS (₹)	-0.1	-0.8	-0.2	0.6	0.5	-0	-0.1	-0	-0	-0.1	0.5
EPS adjusted (₹)	—	—	—	—	—	-0	-0.6	-0.1	-0	-0.1	0.5
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	—	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	6,06,343	6	6	6	6	6
Reserves	6,86,252	6	9	9	9	9
	0	0	0	0	0	0
	8,61,612	0	0	0	0	0
Total equity & liabilities	21,54,206	13	15	15	16	16
	5,534	0	0	0	0	0
CWIP	—	0	0	0	0	0
Investments	1,93,800	0	0	0	0	0
	19,54,872	13	15	15	16	16
Total assets	21,54,206	13	15	15	16	16

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

No ratio history

Ratios derive from annual statements, which haven't been ingested yet.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	25%	25%	25%	25%	25%	25%	25%	25%	25%	25%	25.49%	29.98%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	75%	75%	75%	75%	75%	75%	75%	75%	75%	75%	74.51%	70.02%
No. of shareholders	—	—	—	—	—	—	—	—	4,315	4,306	4,295	4,177

Promoter holding up 4.98 percentage points since Sep 2023.

147 deals · 17 Sept 2021 – 8 May 2026

Date	Client	Type	Venue	Side	Quantity	Price	Value
8 May 2026	MANTHAN RAMESH HIRANI	Bulk	BSE	Buy	34,611	₹30.47	₹0.11 Cr
27 Apr 2026	ANILKUMAR	Bulk	BSE	Sell	43,147	₹31.92	₹0.14 Cr
23 Apr 2026	ADITYA BALASARIA (HUF)	Bulk	BSE	Buy	45,500	₹32.93	₹0.15 Cr
10 Apr 2026	SUKHA SINGH	Bulk	BSE	Sell	40,700	₹28.41	₹0.12 Cr
25 Mar 2026	MOUNA MAHAVEER JAIN	Bulk	BSE	Buy	90,000	₹27.13	₹0.24 Cr
25 Mar 2026	PRAKASHCHAND MUKESHKUMAR	Bulk	BSE	Sell	43,312	₹27.21	₹0.12 Cr
25 Mar 2026	CHAGANLAL PRAKASH CHAND	Bulk	BSE	Sell	35,039	₹27.21	₹0.10 Cr
16 Mar 2026	REETA DEVI	Bulk	BSE	Buy	70,896	₹26.77	₹0.19 Cr
16 Mar 2026	NISHIKANT SINGH	Bulk	BSE	Sell	32,007	₹26.90	₹0.09 Cr
13 Mar 2026	REETA DEVI	Bulk	BSE	Buy	43,310	₹25.82	₹0.11 Cr

1–10 of 147

1 / 15

Mr. DAVENDER SINGHNon-Executive - Non Independent Director
Mr. PARDEEP KUMARNon-Executive - Independent Director
Mr. DINESH KUMARNon-Executive - Independent Director
Mrs. SAKSHI LALLERExecutive Director
Mr. Bharat SinghChief Financial Officer (CFO)
Sameer GuptaCompany Secretary cum Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Prism Medico and Pharmacy Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results12 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

30 announcementsExport CSV

30 Sept 2026, 3:34 pmOthers

Compliance-57 (4) : Prior intimation to the beginning of the quarter

57 (4) : Prior intimation to the beginning of the quarter

Loading announcements…

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Shriram Finance LimitedSHRIRAMFINSHRIRAMFIN	₹1,77,811 Cr	₹4,28,503 Cr	₹49,997 Cr	₹36,981 Cr	73.7%	₹11,318 Cr	20.8%	—	16.4%	—
Tata Capital LimitedTATACAPTATACAP	₹1,35,540 Cr	₹3,71,517 Cr	₹32,695 Cr	₹24,219 Cr	73.2%	₹5,404 Cr	15.5%	—	13.3%	—
Cholamandalam Investment And Finance Company LimitedCHOLAFINCHOLAFIN	₹1,33,352 Cr	₹3,45,452 Cr	₹32,663 Cr	₹22,399 Cr	68.2%	₹5,751 Cr	16.8%	—	19.3%	—
Muthoot Finance LimitedMUTHOOTFINMUTHOOTFIN	₹1,08,289 Cr	₹2,60,075 Cr	₹33,431 Cr	₹27,558 Cr	81.4%	₹11,373 Cr	34%	—	30.9%	—
L&T Finance LimitedLTFLTF	₹66,238 Cr	₹1,76,126 Cr	₹18,928 Cr	₹11,603 Cr	61.1%	₹3,226 Cr	16.7%	—	11.2%	—
Sbi Cards And Payment Services LimitedSBICARDSBICARD	₹53,594 Cr	₹97,658 Cr	₹20,063 Cr	₹5,374 Cr	26.7%	₹2,275 Cr	10.9%	—	14.7%	—
Hdb Financial Services LimitedHDBFSHDBFS	₹51,335 Cr	₹1,38,733 Cr	₹16,300 Cr	₹9,318 Cr	57.2%	₹2,176 Cr	13.4%	—	14.7%	—
Sundaram Finance LimitedSUNDARMFINSUNDARMFIN	₹48,838 Cr	₹1,18,475 Cr	₹10,104 Cr	₹7,957 Cr	78.3%	₹2,220 Cr	21%	—	14.7%	—
Piramal Finance LimitedPIRAMALFINPIRAMALFIN	₹45,868 Cr	₹1,25,857 Cr	₹11,852 Cr	₹7,051 Cr	59.5%	₹1,504 Cr	12.7%	—	5.3%	—
Authum Investment & Infrastructure LimitedAIILAIIL	₹45,797 Cr	₹49,133 Cr	₹2,863 Cr	₹2,451 Cr	88.2%	₹3,582 Cr	74%	—	13.1%	—
Mahindra & Mahindra Financial Services LimitedM&MFINM&MFIN	₹44,445 Cr	₹1,72,816 Cr	₹21,733 Cr	₹13,785 Cr	62.5%	₹3,253 Cr	13.6%	—	11.9%	—
Poonawalla Fincorp LimitedPOONAWALLAPOONAWALLA	₹38,161 Cr	₹86,259 Cr	₹7,813 Cr	₹4,291 Cr	52.7%	₹787 Cr	8%	—	5.9%	—

Date	Category	Subject	Filing
30 Sept 2026, 3:34 pm	Others 57 (4) : Prior intimation to the beginning of the quarter	Compliance-57 (4) : Prior intimation to the beginning of the quarter	PDF
30 Sept 2026, 3:18 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
22 Sept 2026, 6:58 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
19 Sept 2026, 1:48 pm	Company Update General	Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements), Regulations, 2015 - Proceedings Of 24Th Annual General Meeting Held On 19Th September, 2026.	PDF
19 Sept 2026, 1:19 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
26 Aug 2026, 3:55 pm	Others Reg. 34 (1) Annual Report	Reg. 34 (1) Annual Report.	PDF
24 Aug 2026, 6:11 pm	Corp. Action Record Date	Intimation Of Record Date.	PDF
24 Aug 2026, 5:56 pm	Corp. Action Book Closure	Intimation Of Book Closure.	PDF

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-0	-2	3	0	-0	0
	0	2	-3	0	0	0
	0	0	0	-0	0	0
Net cash flow	-0	-0	0	-0	-0	0
Free cash flow	-0	-2	3	0	-0	0
CFO / Operating profit %	—	—	—	—	—	0%

Prism Medico and Pharmacy Ltd

About

Quick read

Pros

Cons

Research score

Peers

Financials

Ratios

No ratio history

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

1

Announcements

Not in the F&O segment

No ratio history

1

No fund holdings on record

Announcements

Annual reports

Compounded sales growth

Compounded profit growth

Return on equity

Prism Medico and Pharmacy Ltd

About

Quick read

Pros

Cons

Research score

Peers

Financials

Profit & loss

Balance sheet

Ratios

No ratio history

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Board meetings1

Announcements

Not in the F&O segment

No ratio history

Board meetings1

No fund holdings on record

Quarterly record

Bulk & block deals

Board and management

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

1

1